FDA greenlights IND application of ADI-270 in renal cell carcinoma - Urology Times

Retrieved on: 2024-06-24 16:33:40

Tags for this article:

Click the tags to see associated articles and topics

FDA greenlights IND application of ADI-270 in renal cell carcinoma - Urology Times. View article details on hiswai:

Excerpt

Preclinical data on ADI-270 were recently presented at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting in Baltimore, ...

Article found on: www.urologytimes.com